Type 3 Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Type 3 Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) [Phase 4]
Phase 4 trial update evaluating aflibercept (Eylea) for efficacy in Type 3 choroidal neovascularization has been completed.